The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
Launch of the CARL. Academy
The CARL Academy is now online! Our new training platform offers customers and interested parties a wide range of training formats as well as extensive background information on the CARL System and CARL Therapy. Using the CARL Academy, customers can expand and check their knowledge with the help of e-learning offers, e-tests and other online formats. In addition, they can qualify for various competence levels as part of the Resuscitec GmbH training concept.
Users can register free of charge in the CARL Academy to receive personal access to all courses on offer and the corresponding study materials. After successful completion of the training courses the respective certificates become accessible to the user on the platform. The platform will be available online to everyone interested from January 1st, 2022.
Registration for the CARL Academy is free of charge. After the login, the user is taken directly to an intuitive interface where he can access information or manage his personal training portfolio, depending on his registration status. The content and structure of the new website are tailored to the level of knowledge and individual needs of different user and professional groups. Registered users who are already working with a CARL System in a clinic can access the training portal directly using the code number of their device.